| Detected | Trial | Change |
|---|---|---|
| 2026-05-29 | NCT07221357 A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy… |
Trial sites expanded: 279 -> 286 locations |
| 2026-05-27 | NCT04929223 A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of… |
Trial sites expanded: 76 -> 82 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07389265 | Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer | Metastatic Colorectal Cancer (mCRC) | Recruiting |
| Phase 2/3 | |||
| NCT07221357 | A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy… | Untreated, Unresectable, or Metastatic Colorectal Cancer | Recruiting |
| NCT03081143 | Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or… | Advanced Gastric or EGJ Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT07061080 | Refractory Advanced diGestive Neuroendocrine Carcinomas Treated With tARlatamab | Advanced Neuroendocrine Carcinomas of The Digestive System | Recruiting |
| NCT07011576 | A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With… | Colon Cancer | Recruiting |
| NCT07446322 | FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of… | Ras-mutated Metastatic Colorectal Cancer | Recruiting |
| NCT06106308 | Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and… | Metastatic Colorectal Cancer | Active, Not Recruiting |
| NCT07337447 | Trial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI With a Hybrid Synthetic Control… | Carcinoma, Neuroendocrine | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT05786924 | Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies | Non-small Cell Lung Cancer | Recruiting |
| NCT07391566 | LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal… | Metastatic Colorectal Cancer (mCRC) | Not Yet Recruiting |
| Phase 1 | |||
| NCT04485013 | TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers | Cancer | Recruiting |
| NCT06179160 | A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors… | Solid Tumors | Recruiting |
| NCT06663319 | A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers | Colorectal Neoplasms | Recruiting |
| NCT04929223 | A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of… | Metastatic Colorectal Cancer | Recruiting |
| Early Phase 1 | |||
| NCT07318389 | ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic… | Dynamic Tumor Resistance | Not Yet Recruiting |